从“浊阴凝痞”视角探究慢性胃炎辨治思路
Perspectives on the Diagnosis and Treatment of Chronic Gastritis Based on the Theory of “Turbid Yin Coagulation and Stagnation”
DOI: 10.12677/tcm.2026.157371, PDF,    科研立项经费支持
作者: 曹思敏, 罗 叙, 刘辰昊, 龙明悦:成都中医药大学临床医学院,四川 成都;刘 毅*:成都中医药大学附属医院消化内科,四川 成都
关键词: 浊阴凝痞慢性胃炎叶天士扶阳Turbid Yin Coagulation and Stagnation Chronic Gastritis Ye Tianshi Strengthening Yang
摘要: 慢性胃炎(chronic gastritis, CG)是一种临床常见的消化道疾病。在中医中属于“胃痞病”、“痞满”、“嘈杂”、“胃痛”等疾病范畴,根本上以脾胃虚弱为本,气滞、血瘀、痰浊为标。笔者从叶天士《临证指南医案》中“浊阴凝痞”视角出发,深入溯源“浊阴”的含义,探索其在慢性胃炎发病过程中的重要作用,以“浊阴凝痞”为基本病机,扶阳运气,化阴除痞为治疗大法,探究慢性胃炎辨治的思路。
Abstract: Objective: Chronic gastritis (CG) constitutes a prevalent clinical disorder of the gastrointestinal tract. In traditional Chinese medicine (TCM), it is categorized under the disease entities including weipi (gastric stuffiness), piman (distention and fullness), cazao (gastric distress and restlessness), weitong (epigastric pain) and analogous syndromes. Pathogenetically, it is rooted in deficiency of the spleen and stomach, with qi stagnation, blood stasis and phlegm turbidity as the secondary manifestations. From the academic perspective of “turbid yin coagulation and stagnation” proposed by Ye Tianshi in his monumental work Medical Cases as a Guide to Clinical Practice, this paper conducts an in-depth textual research on the connotation of “turbid yin”, and elucidates its pivotal role in the pathogenesis of chronic gastritis. Taking “turbid yin coagulation and stagnation” as the core pathogenesis, this study adopts the therapeutic principles of strengthening yang to regulate qi movement, resolving turbid yin and dispelling gastric stuffiness, thereby exploring the systematic thinking of syndrome differentiation and treatment for chronic gastritis.
文章引用:曹思敏, 罗叙, 刘辰昊, 龙明悦, 刘毅. 从“浊阴凝痞”视角探究慢性胃炎辨治思路[J]. 中医学, 2026, 15(7): 141-147. https://doi.org/10.12677/tcm.2026.157371

参考文献

[1] Jiang, J.X., Liu, Q., Mao, X.Y., et al. (2016) Downward Trend in the Prevalence of Helicobacter pylori Infections and Corresponding Frequent Upper Gastrointestinal Diseases Profile Changes in Southeastern China between 2003 and 2012. Springer Plus, 5, Article No. 1601. [Google Scholar] [CrossRef] [PubMed]
[2] 房静远, 杜奕奇, 刘文忠, 等. 中国慢性胃炎诊治指南(2022年, 上海) [J]. 胃肠病学, 2023(3): 149-180.
[3] 杜婷婷, 张志明, 雍文兴, 等. 现代医学慢性胃炎发病及机制研究现状[J]. 实用中医内科杂志, 2021(6): 65-69.
[4] Xiao, S., Shen, Y., Zhang, M., Liu, X., Cai, T. and Wang, F. (2025) VacA Promotes Pyroptosis via TNFAIP3/TRAF1 Signaling to Induce Onset of Atrophic Gastritis. Microbiological Research, 296, Article 128142. [Google Scholar] [CrossRef] [PubMed]
[5] 唐旭东, 王凤云, 李慧臻, 等. 痞满中医临床实践指南(2018) [J]. 中医杂志, 2019(17): 1520-1530.
[6] Banks, M., Graham, D., Jansen, M., Gotoda, T., Coda, S., di Pietro, M., et al. (2019) British Society of Gastroenterology Guidelines on the Diagnosis and Management of Patients at Risk of Gastric Adenocarcinoma. Gut, 68, 1545-1575. [Google Scholar] [CrossRef] [PubMed]
[7] 石松艳, 孙永顺, 李毅平. 中西医结合治疗幽门螺杆菌感染性慢性胃炎的研究进展[J]. 辽宁中医杂志, 2023(8): 241-244.
[8] Santarelli, L., Gabrielli, M., Candelli, M., Cremonini, F., Nista, E.C., Cammarota, G., et al. (2003) Post-Cholecystectomy Alkaline Reactive Gastritis: A Randomized Trial Comparing Sucralfate versus Rabeprazole or no Treatment. European Journal of Gastroenterology & Hepatology, 15, 975-979. [Google Scholar] [CrossRef] [PubMed]
[9] Gong, Y., Huang, X., Chen, M. and Xiong, L. (2019) Teprenone Improves Gastric Mucosal Injury and Dyspeptic Symptoms in Long‐Term Nonsteroidal Anti‐Inflammatory Drug Users. Journal of Gastroenterology and Hepatology, 34, 1344-1350. [Google Scholar] [CrossRef] [PubMed]
[10] Kim, J.Y., Lee, S., Kim, J.H., Sung, I. and Park, H.S. (2020) Efficacy and Safety of Twice a Day, Bismuth-Containing Quadruple Therapy Using High‐Dose Tetracycline and Metronidazole for Second‐Line Helicobacter pylori Eradication. Helicobacter, 25, e12683. [Google Scholar] [CrossRef] [PubMed]
[11] 严茜雅, 郑璨璘, 唐智慧, 等. 幽门螺杆菌多重耐药性对胃肠疾病诊治的挑战与应对策略[J]. 生物工程学报, 2025, 41(4): 1240-1251.
[12] 陆冰云, 陈烨. 雷贝拉唑四联根除幽门螺杆菌感染对肠道微生态影响[J]. 临床军医杂志, 2018(6): 639-641.
[13] 周本刚, 梅宇宙, 颜学良, 等. 养胃颗粒治疗慢性胃炎有效性和安全性的系统评价与Meta分析[J]. 中国中药杂志, 2020, 45(20): 5008-5016.
[14] 张泽丹, 刘峘, 吕健, 等. 香砂养胃丸治疗慢性胃炎的疗效与安全性的系统评价与Meta分析[J]. 中国中药杂志, 2020, 45(11): 2668-2676.
[15] 王慧敏, 秦雪梅, 刘晓节. 脑-肠交互视域下抑郁症与胃肠疾病共病的中西药调节及其机制研究进展[J]. 中草药, 2024, 55(1): 332-343.
[16] 杨洋, 邹多武, 魏玮. 猴头健胃灵片治疗慢性胃炎、消化性溃疡临床应用专家共识[J]. 中国实验方剂学杂志, 2024, 30(20): 96-102.
[17] Tang, X., Zhou, L., Zhang, S., Xu, Y., Cui, Q., Li, L., et al. (2016) Randomized Double-Blind Clinical Trial of Moluodan (摩罗丹) for the Treatment of Chronic Atrophic Gastritis with Dysplasia. Chinese Journal of Integrative Medicine, 22, 9-18. [Google Scholar] [CrossRef] [PubMed]
[18] 王萍, 卞立群, 杨倩, 等. 慢性胃炎中医诊疗专家共识(2023) [J]. 中华中医药杂志, 2023(12): 5904-5911.
[19] 杨宗涛, 赵泽世, 周斌. 基于“始病热中, 末传寒中”理论的慢性胃炎病机演变规律及分阶段论治经验发微[J]. 中华中医药杂志, 2023, 38(10): 4783-4786.
[20] 屈杰, 谭颖颖, 杨景锋, 等. “五脏元真通畅”理论视角下的《金匮要略》温阳法研究[J]. 时珍国医国药, 2024, 35(6): 1439-1441.
[21] 罗智博, 杨关林, 李思琦, 等. 论痰瘀同源[J]. 辽宁中医杂志, 2009, 36(3): 376-379.
[22] 金璐瑶, 王济. 气虚质人群肠道菌群与宿主代谢共变化研究[J]. 中华中医药杂志, 2025, 40(2): 832-834.
[23] 张梵, 王平, 范晶晶, 等. 脏象学说中的食象学说[J]. 中华中医药杂志, 2024, 39(11): 6213-6216.
[24] 汤玲玲, 赵霞, 严花, 等. 江育仁教授“运脾法”治疗小儿脾胃疾病的传承创新与现代诠释[J]. 南京中医药大学学报, 2024, 40(10): 1064-1070.
[25] 刘辰昊, 刘毅. 从“天一生水”论扶阳四逆法的立法之意和运用思路[J]. 中华中医药杂志, 2024, 39(12): 6552-6557.